Matt Beaudet: Driving Innovation with Purpose at Araceli Biosciences
In a standout episode of Hiring For Good, Matt Beaudet—CEO of Araceli Biosciences—offered a masterclass in pragmatic, purpose-driven leadership. With more than 20 years of experience leading some of the biotech industry’s most innovative organizations, Matt brings a grounded and visionary approach to transforming how we accelerate therapeutic discovery.
Beaudet’s career spans leadership roles at influential companies like Molecular Probes, Invitrogen, and Life Technologies. Most recently, he served as CEO of InVivo Biosystems, where he led efforts to raise substantial capital, secure patents, and commercialize novel fluorescence-based assays and instruments. His track record of combining scientific innovation with commercial success has earned him a reputation as a leader who doesn’t just dream big—he builds strategically.
Now at the helm of Araceli Biosciences, Beaudet is focused on scaling the company’s cutting-edge platform to accelerate drug discovery through smarter, more accessible cell-based screening technologies. His leadership is rooted in three core pillars: innovation, collaboration, and real-world impact. On Hiring For Good, he discussed how strong leadership means setting a clear vision, empowering talented teams, and staying grounded in purpose—ensuring that scientific progress is always aligned with meaningful outcomes. Beyond technology, Matt spoke about building high-performance teams. He fosters a culture of cross-functional collaboration where scientists, engineers, and commercial strategists work together from day one. This approach, he believes, is essential to creating products that scale and succeed in the market.
As a long-time champion of Oregon’s biotech ecosystem, Matt’s commitment extends beyond company walls. He’s passionate about nurturing regional talent, investing in future-focused companies, and creating opportunities that drive industry-wide growth.
Our conversation with Matt offers a compelling look at what leadership in the biotech space can and should look like: focused, inclusive, and deeply connected to both science and human need. His voice is a timely reminder that impactful innovation starts with people, and a clear mission to serve them well.
Matt’s Bio
Matt Beaudet is a seasoned biotechnology executive with over 25 years of experience driving innovation and commercialization in the life sciences sector. He currently serves as the CEO of Araceli Biosciences, a Portland-based company specializing in high-content imaging and AI-driven analysis platforms that accelerate drug discovery.
Before joining Araceli, Matt held leadership positions at several influential biotech firms, including Molecular Probes, Invitrogen, and Life Technologies. He also co-founded and served as CEO of InVivo Biosystems, where he led the development and commercialization of fluorescence-based assays and instruments, successfully raising significant capital to support company growth.
Matt's leadership style is characterized by a pragmatic approach to innovation, fostering a culture of collaboration, and a commitment to delivering real-world solutions that meet the needs of researchers and patients. He is passionate about leveraging science to improve health outcomes and is dedicated to mentoring emerging biotech startups, sharing his insights to nurture new talent in the industry.
Holding a degree in Molecular Biology from the University of Oregon, Matt continues to be a driving force in advancing biotechnological research and development.